Motus gi announces positive clinical data for pure-vu evs in three poster presentations at the american college of gastroenterology (acg) 2022 annual scientific meeting

Fort lauderdale, fla., oct. 24, 2022 (globe newswire) -- motus gi holdings, inc., (nasdaq: mots) ("motus gi" or the "company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that three abstracts featuring clinical data on the pure-vu evs were presented in poster sessions at the american college of gastroenterology (acg) 2022 annual scientific meeting, which is being held october 21 to 26, 2022 in charlotte, north carolina. the three abstracts will be published on the motus gi website: https://motusgi.com/physicians-nurses/clinical-evidence/.
MOTS Ratings Summary
MOTS Quant Ranking